Literature DB >> 25231285

Helicobacter pylori induces vascular endothelial growth factor production in gastric epithelial cells through hypoxia-inducible factor-1α-dependent pathway.

Min-Jung Kang1, Eun-Jung Song, Bo-Yeon Kim, Dong-Jae Kim, Jong-Hwan Park.   

Abstract

BACKGROUND: Although Helicobacter pylori have been known to induce vascular endothelial growth factor (VEGF) production in gastric epithelial cells, the precise mechanism for cellular signaling is incompletely understood. In this study, we investigated the role of bacterial virulence factor and host cellular signaling in VEGF production of H. pylori-infected gastric epithelial cells.
MATERIALS AND METHODS: We evaluated production of VEGF, activation of nuclear factor nuclear factor-kappaB (NF-κB) and mitogen-activated protein kinases (MAPKs) and hypoxia-inducible factor-1α (HIF-1α) stabilization in gastric epithelial cells infected with H. pylori WT or isogenic mutants deficient in type IV secretion system (T4SS).
RESULTS: H. pylori induced VEGF production in gastric epithelial cells via both T4SS-dependent and T4SS-independent pathways, although T4SS-independent pathway seems to be the dominant signaling. The inhibitor assay implicated that activation of NF-κB and MAPKs is dispensable for H. pylori-induced VEGF production in gastric epithelial cells. H. pylori led to HIF-1α stabilization in gastric epithelial cells independently of T4SS, NF-κB, and MAPKs, which was essential for VEGF production in these cells. N-acetyl-cysteine (NAC), a reactive oxygen species (ROS) inhibitor, treatment impaired H. pylori-induced HIF-1α stabilization and VEGF production in gastric epithelial cells.
CONCLUSION: We defined the important role of ROS-HIF-1α axis in VEGF production of H. pylori-infected gastric epithelial cells, and bacterial T4SS has a minor role in H. pylori-induced VEGF production of gastric epithelial cells.
© 2014 John Wiley & Sons Ltd.

Entities:  

Keywords:  Helicobacter pylori; Hypoxia-inducible factor-1α; Reactive oxygen species; Type IV secretion system; Vascular endothelial growth factor

Mesh:

Substances:

Year:  2014        PMID: 25231285     DOI: 10.1111/hel.12169

Source DB:  PubMed          Journal:  Helicobacter        ISSN: 1083-4389            Impact factor:   5.753


  10 in total

1.  Helicobacter pylori infection promotes Aquaporin 3 expression via the ROS-HIF-1α-AQP3-ROS loop in stomach mucosa: a potential novel mechanism for cancer pathogenesis.

Authors:  Jianfei Wen; Yao Wang; Cheng Gao; Guoxin Zhang; Qiang You; Weiming Zhang; Zhihong Zhang; Shoulin Wang; Guangyong Peng; Lizong Shen
Journal:  Oncogene       Date:  2018-03-22       Impact factor: 9.867

Review 2.  Polyamine- and NADPH-dependent generation of ROS during Helicobacter pylori infection: A blessing in disguise.

Authors:  Alain P Gobert; Keith T Wilson
Journal:  Free Radic Biol Med       Date:  2016-09-25       Impact factor: 7.376

3.  Serum VEGF Levels in Helicobacter pylori Infection and Correlation with Helicobacter pylori cagA and vacA Genes.

Authors:  Gontar Siregar; Dina Sari; Taufik Sungkar
Journal:  Open Access Maced J Med Sci       Date:  2017-03-19

4.  Helicobacter pylori Induced Phosphatidylinositol-3-OH Kinase/mTOR Activation Increases Hypoxia Inducible Factor-1α to Promote Loss of Cyclin D1 and G0/G1 Cell Cycle Arrest in Human Gastric Cells.

Authors:  Jimena Canales; Manuel Valenzuela; Jimena Bravo; Paulina Cerda-Opazo; Carla Jorquera; Héctor Toledo; Denisse Bravo; Andrew F G Quest
Journal:  Front Cell Infect Microbiol       Date:  2017-03-28       Impact factor: 5.293

Review 5.  Helicobacter pylori Infection is Associated with Occurrence of Proteinuria in Type 2 Diabetes Patients: A Systemic Review and Meta-Analysis.

Authors:  Yan Shi; Jia-Yu Duan; Dong-Wei Liu; Ying-Jin Qiao; Qiu-Xia Han; Shao-Kang Pan; Li Tang; Guang-Yan Cai; Xiang-Mei Chen; Zhang-Suo Liu; Han-Yu Zhu
Journal:  Chin Med J (Engl)       Date:  2018-11-20       Impact factor: 2.628

6.  Withaferin A Inhibits Helicobacter pylori-induced Production of IL-1β in Dendritic Cells by Regulating NF-κB and NLRP3 Inflammasome Activation.

Authors:  Jae-Eun Kim; Jun-Young Lee; Min-Jung Kang; Yu-Jin Jeong; Jin-A Choi; Sang-Muk Oh; Kyung-Bok Lee; Jong-Hwan Park
Journal:  Immune Netw       Date:  2015-12-24       Impact factor: 6.303

Review 7.  HIF-1alpha and infectious diseases: a new frontier for the development of new therapies.

Authors:  Sânia Alves Dos Santos; Dahir Ramos de Andrade
Journal:  Rev Inst Med Trop Sao Paulo       Date:  2017-12-21       Impact factor: 1.846

8.  Helicobacter pylori as an Initiating Factor of Complications in Patients With Cirrhosis: A Single-Center Observational Study.

Authors:  Ahmed Abdel-Razik; Nasser Mousa; Rania Elhelaly; Rasha Elzehery; Ahmad S Hasan; Mostafa Abdelsalam; Ahmed Salah Seif; Ahmed M Tawfik; Niveen El-Wakeel; Waleed Eldars
Journal:  Front Med (Lausanne)       Date:  2020-03-24

Review 9.  Alteration and dysfunction of ion channels/transporters in a hypoxic microenvironment results in the development and progression of gastric cancer.

Authors:  Junling Chen; Minglin Zhang; Zhiyuan Ma; Dumin Yuan; Jiaxing Zhu; Biguang Tuo; Taolang Li; Xuemei Liu
Journal:  Cell Oncol (Dordr)       Date:  2021-04-15       Impact factor: 6.730

10.  Role of the Outer Inflammatory Protein A/Cystine-Glutamate Transporter Pathway in Gastric Mucosal Injury Induced by Helicobacter pylori.

Authors:  Jie Du; Xiao-Hui Li; Fen Liu; Wen-Qun Li; Zhi-Cheng Gong; Yuan-Jian Li
Journal:  Clin Transl Gastroenterol       Date:  2020-05       Impact factor: 4.396

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.